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Abstract
Background Identification of racial differences in the burden
and correlates of carotid intima media thickness (CIMT) and
coronary artery calcium (CAC) may provide the basis for the
development of race-specific cardiovascular disease (CVD)
risk prediction algorithms.
Methods In the Heart Strategies Concentrating on Risk Eval-
uation (Heart SCORE) study, CIMTwas measured by carotid
ultrasonography in 792 individuals (35 % Black). CIMT
>1 mm was considered significant. CAC was quantified by
electron beam computed tomography in 776 individuals
(46 % Black). CACwas considered significant if the Agatston
score was >100. Cross-sectional associations between race,
CIMT and CAC were assessed using logistic regression
models.
Results Blacks had greater CIMT (mean difference
0.033 mm, 95 % CI 0.005–0.06 mm; p=0.02) and 1.5-fold
(95 % CI 1.0–2.3) higher odds of having significant CIMT
than Whites. Blacks had less CAC than Whites (mean
Agatston score difference 66, [11–122]; p=0.02) and 50 %
lower odds of a significant CAC score compared with Whites
(0.5 [0.3–0.7]). These associations were virtually unchanged
after adjustment for CVD risk factors. Of the novel CVD risk
markers assessed, small-dense low-density lipoprotein was
independently associated with increased odds of significant
CIMT, with the association being similar among Blacks and
Whites (odds ratio [95 % CI]: 1.7 [1.2–2.5] and 1.4 [1.0–1.8]
per 1-SD higher level, respectively). Interleukin-6 was signif-
icantly associated with CAC among Blacks (1.4 [1.0–2.0]).
Conclusion Black race is independently associated with
greater CIMT but less CAC than White race. CVD risk
stratification strategies that incorporate these measures of
subclinical atherosclerosis should consider race-specific
algorithms.
Keywords Carotid intimamedia thickness . Coronary artery
calcium . Subclinical atherosclerosis . Racial-disparity . Risk
factor . Observational study
Introduction
Blacks have a >2-fold increased risk of stroke, a similar risk of
coronary artery disease (CAD) morbidity, and a higher risk
CAD mortality compared with Whites [1–4]. These cardio-
vascular disease (CVD) disparities are not fully explained by
differences in traditional CVD risk factors, even though
Blacks have more prevalent hypertension and diabetes [5,
6]. Therefore, evaluation of race-related differences in mea-
sures of subclinical atherosclerosis, which serve as surrogates
for cardiovascular disease (CVD), and the association
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between these measures and both traditional and novel CVD
risk factors may provide a better understanding of racial
disparities in CVD and support the development of race-
specific risk stratification algorithms [6, 7].
Carotid intima media thickness (CIMT) and coronary ar-
tery calcium (CAC) score are two well-established measures
of subclinical atherosclerosis that are used to stratify future
risk of CVD events [6, 8–16]. Previous studies have reported
inter-ethnic differences in the burden of CIMT and CAC. For
instance, Blacks have a higher CIMT burden than Whites [6,
17, 18], although it is unclear whether this finding correlates
with a greater burden of carotid plaque [17]. In contrast, we
and others have reported a lower CAC burden in Blacks [9,
10, 19–21], although this finding is controversial [22, 23]. As
in the case of stroke and CAD, observed inter-racial differ-
ences in CIMT and CAC burden are not fully explained by
traditional CVD factors [6, 9, 10, 24]. Accordingly, we
analysed data from the Heart Strategies Concentrating on Risk
Evaluation (Heart SCORE) study [7, 9] to provide insight into
race-specific CVD risk prediction. Specifically, we investigat-
ed inter-racial differences in CIMTand CAC burden, and their




Heart SCORE is an ongoing community-based prospective
cohort study of racial disparities of CVD with approximately
equal representation of Blacks and Whites. The methods of
Heart SCORE have been described previously [7, 9]. Eligibility
criteria included age 45 to 75 years at study entry, residence in
the greater Pittsburgh metropolitan area, ability to undergo
baseline and annual follow-up visits, and absence of known
comorbidities expected to limit life expectancy to less than
5 years. The present report is based on cross-sectional analyses
of 1,245 participants who had available information on either
CIMT or CAC, including 327 individuals with information on
both variables. The Institutional ReviewBoard at theUniversity
of Pittsburgh approved the study protocol, and all study subjects
provided written informed consent.
Data collection
Detailed demographic and medical histories were collected at
the baseline visit. Race was self-reported. Physical examina-
tion included measurement of vital signs and anthropometric
measures of body fat distribution. Body mass index (BMI)
was calculated as weight/height2 (kg/m2). Diabetes mellitus
was defined as fasting glucose >126 mg/dl based on clinical
guidelines at the time of study initiation or a history of
previously diagnosed diabetes treated with diet, oral agents,
and/or insulin.
Laboratory assessments of lipoprotein levels and particle
sizes were performed on venous blood drawn in the fasting
state. The amount of cholesterol contained in each lipoprotein
particle subfraction was quantified by a commercial laborato-
ry using the vertical auto profile technique (VAP, Atherotech,
Birmingham, AL). This method was also used to quantify
concentrations of proatherogenic, small-dense low-density
lipoprotein (sdLDL). Fasting blood glucose was measured
using the glucose oxidase method. Measurement of high-
sensitivity C-reactive protein (hsCRP) was performed using
an immunoturbidimetric assay on the Roche P Modular sys-
tem (Roche Diagnostics - Indianapolis, IN), using reagents
and calibrators from DiaSorin (Stillwater, MN). Concentra-
tions of serum interleukin-6 (IL-6), soluble intercellular adhe-
sion molecule 1 (sICAM-1), CD40 ligand (CD40L) and
endostatin were measured using commercially available
ELISA assay kits (R&D Systems, Minneapolis, MN). Mea-
surements were performed using a standard curve provided
with the ELISA kits; samples were read spectrophotometri-
cally in a microtitre plate reader. To confirm reproducibility as
reported by the kit manufacturer, a random subset of samples
(10 %) was assayed in duplicate. The selection of the novel
markers measured in this study was based on information
from previous reports of associations between CVD and var-
ious pro-inflammatory cytokines, soluble cellular adhesion
molecules and growth regulatory factors [25–28].
Carotid artery imaging
Carotid artery imaging was carried out using a GE VIVID7
(General Electric Corp.) ultrasound imaging system and a
7 MHz linear array vascular ultrasound probe. The ultrasound
beam was adjusted to obtain longitudinal scans of the carotid
arteries to visualise two parallel echogenic lines correspond-
ing to the blood-intima and media-adventitia interfaces on the
posterior wall. End-diastolic images were recorded using
electrocardiographic gating. Software on the GE VIVID 7
was used to calculate intima media thickness using automated
edge detection to locate the lumen-intima and media-
adventitia echo boundaries at subpixel resolution [29]. Media
thickness averaged over 70–100 individual measurements
taken along a 1-cm segment of the common carotid artery
beginning 0.5 cm from the carotid bifurcation along the far
wall of the distal common carotid artery. Significant CIMT
was defined as maximal CIMT >1 mm in either the right or
left carotid artery, as previously described by others [29].
Coronary artery calcium measurement
Electron beam computed tomography image acquisition was
obtained with Imatron C150 scanner (GE Imatron Inc, South
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San Francisco, CA) using 3-mm intervals to span the heart
during a single inspiratory breath-hold. Calcium scores were
calculated by the Agatston method using a densitometric
program [30]. Scans were interpreted by an experienced read-
er blinded to subject identities. Significant CAC scores were
defined as an Agatston score of >100, which corresponds to
significant CAC burden, as previously described [9, 30].
Statistical analysis
Baseline characteristics of Black and White participants were
compared using chi-squared tests (for categorical variables) or
Student’s t test (for continuous variables). Variables with
skewed distributions (i.e., CRP and IL-6) were log-
transformed to approximate normal distribution, before apply-
ing the t-test or fitting in regressionmodels. The association of
race with presence of significant CIMT or CAC was assessed
using logistic regression models. Covariates used for statisti-
cal adjustment included conventional CVD risk factors (age,
sex, smoking, BMI, systolic blood pressure, LDL-cholesterol,
HDL-cholesterol and log-triglycerides), and novel risk
markers (sdLDL, CRP, IL-6, sICAM-1, CD40L and
endostatin). All analyses were performed using Stata software
(Stata Corp., version 11, Texas, USA).
Results
Demographics
Data on CIMT and CAC were available on 792 (514 White,
278 Black) and 776 (414 White, 362 Black) participants,
respectively. Of these, 327 participants underwent both CIMT
and CAC measurement. Overall, the mean age of participants
was 60 years with 42 % males and 11 % smokers. The
characteristics of the participants subgrouped by race are
shown in Tables 1a and b. As shown in these tables, White
participants were older than the Black participants. Also, the
proportion of males was higher among the White participants.
Blacks had a significantly higher prevalence of diabetes, as
well as higher mean BMI and systolic blood pressure, and
higher CRP and IL-6 levels but lower levels of triglycerides
and sdLDL, compared with Whites (these differences
persisted in multivariable adjusted regression models includ-
ing age, sex, smoking status and diabetes). Supplementary
Tables 1a and 1b show the characteristics of the participants
subgrouped by sex.
Race and CIMT
Blacks had higher CIMT than Whites (mean difference
0.033 mm, 95 % CI 0.005–0.06 mm; p =0.02) and a 1.5-fold
(95 % CI 1.0–2.3) greater odds of having significant CIMT.
These higher odds were virtually unchanged after adjustment
for conventional CVD risk factors (odds ratio [95 % CI]: 1.6
[1.0–2.6]; Table 2). The association of traditional CVD risk
factors with CIMT is shown in Supplementary Table 2; in
particular age, sex and smoking were strongly associated with
risk of significant CIMT. Of the novel factors assessed,
sdLDL was associated with higher odds of having significant
CIMT after adjustment for CVD risk factors, with the associ-
ation being relatively similar among Blacks and Whites (1.7
[1.2–2.5] and 1.4 [1.0–1.8] per 1-SD higher sdLDL level,
respectively) (Table 3).
Race and CAC
Blacks had lower CAC than Whites (mean Agatston score
difference 66, 11–122; p=0.02) and a 50 % lower odds of a
significant CAC score (odds ratio [95 % CI]: 0.5 [0.3-0.7]).
The association was unchanged after adjustment for CVD risk
factors (0.5 [0.3–0.7]; Table 2). The association of traditional
CVD risk factors with CAC is shown in Supplementary
Table 2; in particular age and sex were strongly associated
with risk of significant CAC. Of the novel factors, IL-6 was
significantly associated with CAC (1.3[1.0, 1.6]). This asso-
ciation was evident among Blacks (1.4 [1.0–2.0]) and trended
among Whites (1.2 [0.9–1.6]) (Table 3).
Subsidiary analyses
Sensitivity analyses of 327 (205White, 122 Black) participants
with available information on both CIMT and CAC yielded
similar results, although the association of race with CIMTwas
not statistically significant in the fully adjusted model, partly
due to limited statistical power (Table 4). In this subset, indi-
viduals with significant CIMT (>1 mm) had higher risk of
having significant CAC (odds ratio [95 % CI]: 2.2 [1.3–3.9]);
however, this association was no longer statistically significant
after adjustment for age, sex, race and conventional CVD risk
factors (1.5 [0.8–2.8]) (data not presented in tables).
Discussion
Our data frommore than 1,200 participants in a study of racial
disparities in CVD indicate that Black race is associated with
higher CIMT but less CAC than White race. These associa-
tions were independent of traditional CVD risk factors. Of the
novel CVD risk factors that were investigated, sdLDL was
found to be significantly associated with CIMT but not with
CAC. Interleukin-6 concentration was significantly associated
with higher CAC in Blacks, and trended in the same direction
in Whites.
46 Neth Heart J (2015) 23:44–51
Racial differences in the burden of subclinical atheroscle-
rosis, which is a surrogate marker of CVD, have been previ-
ously reported [6, 10, 18–21]. For instance, Kanaya et al.
compared US Asians in the MASALA study with Whites,
African Americans, Latin Americans and Chinese Americans
in the MESA study. They found that South Asians andWhites
have similar CAC scores, but that their CAC scores were
higher than those in the other ethnic groups, including African
Americans [31]. Our findings of higher CAC burden in
Whites than Blacks are consistent with their report. Moreover,
our study complements previous studies on the topic because
we concomitantly investigated CIMT and CAC in a racially
diverse study population and determined their associations
with both conventional and novel CVD risk factors. Our study
confirms significant inter-racial differences in CIMT and
CAC, and reports their correlations with traditional and novel
Table 1 a: Baseline characteristics of 792 participants with available information on carotid intima media thickness (CIMT) by race. b: Baseline
characteristics of 776 participants with available information on coronary artery calcium (CAC) score by race
Variable Whites Blacks p-value
No of subjects Mean (SD) or N (%) No of subjects Mean (SD) or N (%)
a) Individuals with available data on CIMT
Maximum CIMT (mm) 514 0.81 (0.19) 278 0.84 (0.18) 0.019
Age (years) 514 60 (7) 278 58 (7) <0.001
Male 514 205 (40 %) 278 83 (30 %) 0.005
Current smoker 513 30 (6 %) 278 24 (9 %) 0.14
History of diabetes 510 22 (4 %) 277 31 (11 %) <0.001
Systolic blood pressure 514 133 (18) 278 140 (20) <0.001
Body mass index 506 28 (5) 274 32 (6) <0.001
LDL cholesterol (mg/dl) 514 143 (34) 278 140 (40) 0.17
HDL cholesterol 514 55 (17) 278 58 (16) 0.08
Triglycerides (mg/dl) 514 134 (83) 278 105 (48) <0.001
Fasting glucose (mg/dl) 511 96 (18) 277 99 (27) 0.10
sdLDL cholesterol (mg/dl) 514 48 (19) 278 43 (19) <0.001
log-CRP (log-mg/dl) 487 0.13 (1.14) 257 0.49 (1.21) <0.001
log-IL6 (log-mg/dl) 480 0.31 (0.77) 250 0.66 (0.68) <0.001
CD40L (ng/ml) 359 2.75 (2.79) 184 1.55 (1.68) <0.001
sICAM-1 (ng/ml) 429 232 (70) 234 197 (97) <0.001
Endostatin (ng/ml) 379 125 (34) 199 123 (44) 0.50
b) Individuals with available data on CAC
Total CAC score 414 190 (391) 362 124 (399) 0.01
Age (years) 414 61 (7) 360 60 (7) 0.001
Male 414 258 (62 %) 360 163 (45 %) < 0.001
Current smokers 413 47 (11 %) 358 65 (18 %) 0.01
Diabetes history 411 49 (12 %) 359 97 (27 %) <0.001
Systolic blood pressure 414 140 (20) 360 146 (19) <0.001
Body mass index 410 30 (6) 359 32 (6) <0.001
LDL cholesterol (mg/dl) 414 146 (36) 360 144 (41) 0.47
HDL cholesterol 414 48 (14) 360 52 (16) <0.001
Triglycerides (mg/dl) 414 159 (106) 360 121 (71) <0.001
Fasting glucose (mg/dl) 411 101 (21) 359 108 (40) <0.001
sdLDL cholesterol (mg/dl) 418 53 (20) 362 48 (20) <0.001
Log-CRP (log-mg/dl) 389 0.22 (1.10) 340 0.70 (1.21) <0.001
Log-IL6 (log-mg/dl) 384 0.43 (0.73) 334 0.78 (0.66) <0.001
CD40L (ng/ml) 137 2.47 (2.74) 90 1.70 (1.61) 0.017
sICAM-1 (ng/ml) 353 244 (85) 311 197 (104) <0.001
Endostatin (ng/ml) 149 124 (34) 96 127 (44) 0.59
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CVD risk factors. The present report builds on our previous
work that demonstrated a difference in CAC burden between
Blacks and Whites [7, 9] in that we studied CIMT, in addition
to CAC, and were able to assess their associations with race
and several novel inflammatory markers.
In our study, higher levels of IL-6 were associated with a
greater burden of CAC in Blacks, and showed a trend in
Whites. Also, higher levels of sdLDL concentrations were
significantly associated with greater burden of CIMT in both
Blacks andWhites. Of note, this association appeared stronger
in Blacks than Whites (adjusted odds ratio = 1.7 versus 1.4),
but the difference was not statistically significant. Compared
with large buoyant LDL particles, sdLDL particles have in-
creased penetration into the arterial wall and increased
Table 2 The association of race with adjusted odds of significant carotid intima media thickness (>1 mm) and coronary artery calcification (Agatston
Score >100)
Model and covariates Significant carotid intima media thickness
(>1 mm)
Coronary artery calcification (Agatston
Score >100)
No. available OR (95 % CI) for
Black vs. White
χ2 No. available OR (95 % CI) for
Black vs. White
χ2
Crude 792 1.51(1.01,2.26) 4.1 776 0.47(0.34,0.65) 21.7
Adjusted for age and sex 792 1.91(1.26,2.92) 9.1 776 0.59(0.42,0.83) 9.0
Above plus adjusted for SBP, smoking, diabetes, and BMI 776 1.59(1.02,2.47) 4.2 767 0.49(0.34,0.70) 15.3
Above plus adjusted for total cholesterol, HDL-c,
triglycerides and fasting glucose level
772 1.62(1.02,2.57) 4.2 763 0.50(0.35,0.73) 13.0
Table 3 The association of novel risk markers with adjusted odds* of significant carotid intima media thickness (>1 mm) and coronary calcification
(Agatston Score >100), overall and by race
Marker Significant carotid intima media thickness (>1 mm) Significant coronary artery calcification (Agatston Score >100)
N available OR (95 % CI) per
1-SD higher level




sdLDL 776 1.43(1.14,1.79) 9.7 767 0.92(0.77,1.10) 0.8
CD40L 531 0.96(0.71,1.29) 0.1 223 1.06(0.74,1.52) 0.1
Log-CRP 725 1.00(0.77,1.30) 0.0 716 1.05(0.84,1.30) 0.2
Log-IL-6 711 1.20(0.93,1.54) 2.0 704 1.28(1.04,1.58) 5.2
Endostatin 565 0.90(0.69,1.16) 0.7 240 1.04(0.75,1.44) 0.0
sICAM-1 648 0.84(0.63,1.12) 1.4 654 1.07(0.88,1.31) 0.5
Race Variable Significant carotid intima media thickness (>1 mm) Significant coronary artery calcification (Agatston Score >100)
N available OR (95 % CI) per
1-SD higher level
χ2 N available OR (95 % CI) per
1-SD higher level
χ2
b) Association by race
White sdLDL 503 1.36(1.01,1.83) 4.2 410 0.98(0.78,1.24) 0.0
CD40L 349 0.89(0.62,1.28) 0.4 133 1.16(0.77,1.74) 0.5
Log-CRP 473 1.03(0.72,1.46) 0.0 380 1.03(0.77,1.39) 0.1
Log-IL-6 466 1.21(0.88,1.66) 1.3 375 1.19(0.91,1.56) 1.6
Endostatin 368 0.91(0.60,1.37) 0.2 144 0.93(0.59,1.45) 0.1
sICAM-1 405 0.99(0.63,1.55) 0.0 346 1.06(0.79,1.41) 0.1
Black sdLDL 273 1.73(1.19,2.50) 8.3 357 0.84(0.63,1.12) 1.4
CD40L 182 1.16(0.65,2.08) 0.3 82 1.06(0.35,3.16) 0.0
Log-CRP 252 0.95(0.63,1.43) 0.1 336 1.04(0.74,1.45) 0.0
Log-IL-6 245 1.21(0.79,1.84) 0.8 329 1.40(0.98,1.98) 3.5
Endostatin 197 0.84(0.58,1.20) 0.9 88 1.57(0.80,3.07) 1.7
sICAM-1 230 0.75(0.51,1.11) 2.1 308 1.06(0.79,1.41) 0.2
*Adjustment for age, sex, race, systolic blood pressure, smoking status, diabetes, bodymass index, total cholesterol, HDL-c, triglycerides and fasting glucose
Total cholesterol was not adjusted for when assessing the association of sdLDL
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susceptibility to oxidation. Hence sdLDL is believed to be
more pro-atherogenic than larger LDL particles [32]. Similar-
ly, inflammation is known to play an important role in the
progression of atherosclerotic plaque [33, 34]. For example,
recent genetic studies have shown IL-6 to be a likely causal
factor in CVD [35]. In our study, we found that sdLDL and IL-
6 were associated with CIMT and CAC, respectively. Given
the higher burden of CIMT and lower burden of CAC in
Blacks, one would expect higher levels of sdLDL and lower
levels of IL-6 in Blacks compared with Whites. However, our
findings demonstrate the opposite; Blacks had significantly
lower levels of sdLDL and higher levels of IL-6. This is likely
because CAC and CIMTare multifactorial surrogates of CVD
that are determined by the interaction of several variables,
besides sdLDL and IL-6 concentrations. In addition, the con-
centrations sdLDL and IL-6 in blood may influence other
characteristics of CAC and CIMT, such as ‘plaque vulnera-
bility’ (see below). We also found that sICAM-1 and CD40L
were not associated with either CIMT or CAC, in keeping
with previous studies showing lack of association of these
novel risk markers with CVD [25, 33].
Coronary artery calcium burden has been shown to be a
predictor of CVD risk [11, 15, 16]. Therefore, it is surprising
that Blacks, who have higher rates of stroke and CVD mor-
tality thanWhites, have lower burdens of CAC thanWhites as
reported in previous epidemiological studies [10, 19–21]. Our
study similarly found a substantially lower burden of CAC in
Blacks compared with Whites. One proposed hypothesis for
this paradoxical observation is that the level of CAC may not
only be determined by traditional CVD risk factors, but also
by certain aspects of calcium and vitamin D metabolism [36,
37]. For instance, Blacks as a group, have lower levels of
vitamin D thanWhites [38, 39]. Regardless of the mechanistic
explanation for the lower calcium scores in Blacks, it is
apparent that the use of the currently accepted cut-offs of
CAC scores to predict CVD risk are more relevant to Whites
than Blacks. On the other hand, the generally higher concen-
trations of inflammatory mediators (e.g., hsCRP, IL-6) ob-
served in Black participants in our study, and the established
role of inflammation in atherosclerotic plaque instability
[40–42], suggests that the increased risk of CVD in Blacks
may be related to higher plaque vulnerability of less calcified
coronary lesions. Therefore, our data support previous sug-
gestions that Agatston score cut-offs for risk categories are
most clinically relevant if defined separately by race [43, 44].
Additional data from large prospective studies that measure
CAC, CVD risk factors, and incident CVD outcomes con-
comitantly in both Blacks and Whites would be required to
establish such cut-points. The determination of such ethnicity-
specific cut-points may improve CVD risk stratification and
preventive measures.
As with CAC, CIMT is a widely accepted indicator of
CVD risk and has been shown to predict future risk of stroke
and coronary events [8, 12–14]. In contrast to overall lower
levels of CAC in Blacks compared with Whites, several
studies, including ours, have demonstrated higher burden of
CIMT in Blacks than Whites [6, 18]. These Black-White
differences in CIMT have also been observed in children
and adolescents, indicating that it is less likely to be explained
by traditional CVD risk factors such as smoking [24]. A recent
meta-analysis of eight observational studies showed that a
0.1 mm higher CIMTwas associated with about a 15 % higher
risk of CVD [8]. The mean racial difference in CIMT in our
study was only 0.03, and the mean CIMT among Whites was
greater than previously reported (0.81 vs. 0.75 mm) [17]. How-
ever, a substantial proportion of Blacks had CIMT >1 mm,
compared with Whites, suggesting that the majority of the
inter-racial disparity in CIMT may exist at the higher end of
the spectrum. This finding supports the need for large prospec-
tive epidemiological studies of CVD outcomes to assess race-
specific algorithms of CIMT as a predictor of CVD risk.
The strengths of the current study merit consideration. First,
the study assessed CIMT and CAC in a general population
composed of two races (Blacks and Whites), thereby allowing
better characterisation of their relationships with race. Second,
with >700 participants in each subset, the study was adequately
powered to assess associations between race and subclinical
atherosclerosis. Third, we had available data on a range of
Table 4 The association of race with adjusted odds of significant carotid intima media thickness (>1 mm) and coronary artery calcification (Agatston
Score >100) in a subset of 327 participants with available information on both measures of subclinical atherosclerosis
Model and covariates Significant carotid intima media thickness
(>1 mm)
Significant coronary artery calcification
(Agatston Score >100)
N available OR (95 % CI) for
Black vs. White
χ2 N available OR (95 % CI) for
Black vs. White
χ2
Crude 327 1.03(0.59,1.80) 0.0 327 0.44(0.26,0.74) 9.6
Adjusted for age and sex 327 1.35(0.75,2.43) 1.0 327 0.50(0.29,0.88) 5.9
Above plus adjusted for SBP, smoking, diabetes, and BMI 323 1.24(0.67,2.30) 0.4 323 0.37(0.20,0.68) 10.2
Above plus adjusted for total cholesterol, HDL-c,
triglycerides, and fasting glucose level
323 1.37(0.71,2.67) 0.9 323 0.35(0.18,0.65) 10.8
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traditional and novel CVD risk factors thereby enabling detailed
exploration of their role in the observed associations.
Our study also has a number of limitations. First, only a
subset of our subjects had available data on both CIMT and
CAC. Hence the separate analyses performed on CIMT and
CAC were not directly comparable. However, sensitivity
analyses of 327 participants with information on both CIMT
and CAC yielded similar results. Second, the cross-sectional
nature of our study limits the degree of inference that may be
drawn. Third, due to lack of tabulation of ‘hard’ CVD out-
comes, it is not possible to make specific recommendations of
race-specific algorithms for characterising incident CVD risk
using CIMT and CAC. Finally, we did not investigate certain
aspects of inter-ethnic differences in cardiac variables, such as
differences in cardiac morphology, which may influence CVD
outcomes [45].
In conclusion, the current study provides evidence that
Black race is associated with greater CIMT but less CAC than
White race independent of conventional CVD risk factors.
Small-dense LDL was associated with significant CIMT in
both races, while IL-6 was associated with significant CAC
burden in Blacks. The results suggest that additional studies
are needed to develop race-specific algorithms for CVD risk
stratification strategies that incorporate measures of subclini-
cal atherosclerosis.
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